European Journal of Biomedical and Pharmaceutical Sciences

TO STUDY THE EFFICACY OF AYURVEDA-BASED COMPREHENSIVE DIABETIC CARE (CDC) PROGRAM IN OVERWEIGHT MALE TYPE-II DIABETIC PATIENTS

*Dr. Pallavi Patil Pawar, BAMS, MD and Dr. Diwakar Pawar, BAMS, FPC

ABSTRACT

In India, it is estimated that around 1/10th of the population is inflicted by DM, with significantly high mortality rates. Despite availability of plethora of therapeutic options for treatment of type II DM, its prevalence and contribution to global morbidity and mortality remains significantly high and is increasing continuously. The HbA1c levels are more important as it is an independent predictor of mortality and morbidity in diabetic patients and also reflects the average blood sugar control over the past 1-2 months. Hence, this study was conducted to evaluate the efficacy of Ayurveda-Based CDC program on Glycosylated hemoglobin (HbA1c) in overweight male Type-II DM Patients. Methods: This study was conducted from March 2017 to May 2018, Data of Type II DM patients who had received minimum 6 CDC sittings over 90 days(±15 days) and followed low carb diet plan in the out-patient departments(OPDs) at Madhavbaug clinics in Kolhapur, Maharashtra was identified. The patients were administered with Panchkarma therapy namely Snehana i.e. oleation, Swedana i.e. passive heat therapy and Basti of Gudmaar(Gymnema sylvestre), Daruharidra(Berberis aristate) and Yashtimadhu (Glycyrrhiza glabra) 100 ml Kwatha i.e. per rectal drug administration. In this study, the variables [HbA1c, weight, BMI, abdominal girth and dependency on medications] were assessed on day 1 and day 90 of CDC. Results: Fifteen male overweight male Type II diabetic patients were considered for analysis. There was significant improvement in HbA1c by 1.58%(from 8.38±1.24 to 6.8±0.52; p<0.001), weight by 4.05kg (from 76.37±8.09 to 72.31±8.17, p<0.001). BMI(from 27.44±2.28 to 25.87±2.05; p<0.001) and Abdominal girth(from 99.8±6.97 to 94.33±7.68; p<0.001) also showed significant reduction. Conclusion: Ayurveda-based CDC program found to be efficacious by reducing HbA1c in overweight male Type-II diabetic patients.

Keywords: Madhavbaug Daruharidra(Berberis aristate) and Yashtimadhu (Glycyrrhiza glabra) patients.